US Patent Issued to NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY on June 9 for "Ketorolaco derivative, pharmaceutical composition and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,746, issued on June 9, was assigned to NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY Co. LTD. (Nanjing, China).

"Ketorolaco derivative, pharmaceutical composition and preparation method therefor and use thereof" was invented by Hai Ye (Nanjing, China), Tao Min (Nanjing, China), Tian Lv (Nanjing, China), Wenliang Zhou (Nanjing, China), Xingran Chen (Nanjing, China), Yunqing Feng (Nanjing, China), Meiling Mo (Nanjing, China) and Jialin Wang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A ketorolaco derivative as shown in formula (I) has a better half-life and stability, has good pharmacokinetic properties, and has a higher stabil...